Efficacy and Safety of Liraglutide vs. Placebo as Add-on to Existing Diabetes Medication in Subjects with Type 2 Diabetes (T2DM) and Moderate Renal Impairment (LIRA-RENAL)
journal contribution
posted on 2024-09-20, 03:06authored byMelanie Davies, Stephen Atkin, Stephen C Bain, David ScottDavid Scott, Peter Rossing, Minara Shamkhalova, Heidrun Bosch-Traberg, Annika Syren, Guillermo E Umpierrez
Efficacy and Safety of Liraglutide vs. Placebo as Add-on to Existing Diabetes Medication in Subjects with Type 2 Diabetes (T2DM) and Moderate Renal Impairment (LIRA-RENAL)